Journal Title：Global Heart

Global Heart offers a forum for dialogue and education on research, developments, trends, solutions and public health programs related to the prevention and control of cardiovascular diseases (CVDs) worldwide, with a special focus on low- and middle-income countries (LMICs). Manuscripts should address not only the extent or epidemiology of the problem, but also describe interventions to effectively control and prevent CVDs and the underlying factors. The emphasis should be on approaches applicable in settings with limited resources.

Economic evaluations of successful interventions are particularly welcome. We will also consider negative findings if important. While reports of hospital or clinic-based treatments are not excluded, particularly if they have broad implications for cost-effective disease control or prevention, we give priority to papers addressing community-based activities. We encourage submissions on cardiovascular surveillance and health policies, professional education, ethical issues and technological innovations related to prevention.

Global Heart is particularly interested in publishing data from updated national or regional demographic health surveys, World Health Organization or Global Burden of Disease data, large clinical disease databases or registries. Systematic reviews or meta-analyses on globally relevant topics are welcome. We will also consider clinical research that has special relevance to LMICs, e.g. using validated instruments to assess health-related quality-of-life in patients from LMICs, innovative diagnostic-therapeutic applications, real-world effectiveness clinical trials, research methods (innovative methodologic papers, with emphasis on low-cost research methods or novel application of methods in low resource settings), and papers pertaining to cardiovascular health promotion and policy (quantitative evaluation of health programs.

Global Heart 為全球范圍內(nèi)預(yù)防和控制心血管疾病 (CVD) 的研究、發(fā)展、趨勢(shì)、解決方案和公共衛(wèi)生計(jì)劃提供了一個(gè)對(duì)話和教育的論壇，特別關(guān)注中低收入國(guó)家 (LMIC)。稿件不僅應(yīng)解決問題的程度或流行病學(xué)，還應(yīng)描述有效控制和預(yù)防 CVD 及其潛在因素的干預(yù)措施。重點(diǎn)應(yīng)放在資源有限的情況下適用的方法上。

特別歡迎對(duì)成功干預(yù)措施進(jìn)行經(jīng)濟(jì)評(píng)估。如果負(fù)面發(fā)現(xiàn)很重要，我們也會(huì)考慮。雖然醫(yī)院或診所治療的報(bào)告不被排除，特別是如果它們對(duì)具有成本效益的疾病控制或預(yù)防具有廣泛的影響，但我們優(yōu)先考慮涉及社區(qū)活動(dòng)的論文。我們鼓勵(lì)投稿關(guān)于心血管監(jiān)測(cè)和健康政策、專業(yè)教育、道德問題和預(yù)防相關(guān)技術(shù)創(chuàng)新的文章。

Global Heart 特別希望發(fā)表來自最新國(guó)家或地區(qū)人口健康調(diào)查、世界衛(wèi)生組織或全球疾病負(fù)擔(dān)數(shù)據(jù)、大型臨床疾病數(shù)據(jù)庫(kù)或登記處的數(shù)據(jù)。歡迎對(duì)全球相關(guān)主題進(jìn)行系統(tǒng)評(píng)價(jià)或薈萃分析。我們還將考慮與中低收入國(guó)家特別相關(guān)的臨床研究，例如使用經(jīng)過驗(yàn)證的工具評(píng)估中低收入國(guó)家患者的健康相關(guān)生活質(zhì)量、創(chuàng)新診斷治療應(yīng)用、真實(shí)世界有效性臨床試驗(yàn)、研究方法（創(chuàng)新方法論文，重點(diǎn)是低成本研究方法或在資源匱乏環(huán)境中的新方法應(yīng)用）以及與心血管健康促進(jìn)和政策相關(guān)的論文（健康計(jì)劃的定量評(píng)估）。

Global Heart創(chuàng)刊于2011年，由Elsevier Science & Technology出版商出版，收稿方向涵蓋Medicine - Cardiology and Cardiovascular Medicine全領(lǐng)域，此刊是中等級(jí)別的SCI期刊，所以過審相對(duì)來講不是特別難，但是該刊專業(yè)認(rèn)可度不錯(cuò)，仍然是一本值得選擇的SCI期刊 。平均審稿速度 5 Weeks ，影響因子指數(shù)3，該期刊近期沒有被列入國(guó)際期刊預(yù)警名單，廣大學(xué)者值得一試。